20-36793253-T-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_080627.4(MTCL2):āc.4829A>Gā(p.Asn1610Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,550,776 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_080627.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTCL2 | NM_080627.4 | c.4829A>G | p.Asn1610Ser | missense_variant | 14/15 | ENST00000237536.9 | NP_542194.2 | |
MTCL2 | NM_199181.3 | c.2993+1122A>G | intron_variant | NP_954650.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOGA1 | ENST00000237536.9 | c.4829A>G | p.Asn1610Ser | missense_variant | 14/15 | 5 | NM_080627.4 | ENSP00000237536.4 | ||
SOGA1 | ENST00000279034.10 | c.2993+1122A>G | intron_variant | 5 | ENSP00000279034.5 | |||||
SOGA1 | ENST00000465671.1 | n.3668A>G | non_coding_transcript_exon_variant | 10/12 | 2 | ENSP00000433939.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000128 AC: 2AN: 156002Hom.: 0 AF XY: 0.0000121 AC XY: 1AN XY: 82482
GnomAD4 exome AF: 0.00000715 AC: 10AN: 1398456Hom.: 0 Cov.: 30 AF XY: 0.0000101 AC XY: 7AN XY: 689708
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74482
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at